3 completed, 2 active not recruiting, 1 recruiting. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 3, Active not recruiting 2, Recruiting 1 |
Follow Abiraterone Acetate: new trials by email Literature Review of Abiraterone Acetate trials Research Report on Abiraterone Acetate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study) Oxycodone oral capsule 15 mg, Abiraterone Acetate Tablets 500 mg - Prostate Cancer, Pain Cancer | Phase 4 | Recruiting | Deventer Ziekenhuis | 29 | 2024-04-12 | 2025-06-03 |
| Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations olaparib, enzalutamide, abiraterone acetate - Metastatic Castration-resistant Prostate Cancer | Phase 4 | Active not recruiting | AstraZeneca | 43 | 2022-07-29 | 2026-04-21 |
| Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer GnRH agonist/antagonist, Prednisone, Abiraterone Acetate - Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma | Phase 4 | Active not recruiting | Northwestern University | 100 | 2017-03-31 | 2026-02-24 |
| Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent cabazitaxel XRP6258, enzalutamide, abiraterone acetate - Prostate Cancer Metastatic | Phase 4 | Completed | Sanofi | 255 | 2015-11-09 | 2022-05-27 |
| A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy Abiraterone Acetate, Prednisolone - Metastatic Castration-Resistant Prostate Cancer | Phase 4 | Completed | Janssen Pharmaceutical K.K. | 51 | 2015-04-10 | 2025-02-03 |
| Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients Enzalutamide, Abiraterone, Placebo for Enzalutamide - Prostate Cancer | Phase 4 | Completed | Pfizer | 509 | 2013-10-22 | 2023-09-18 |
Prostatic Neoplasms (3) · Cancer Pain (1) · Cognitive Dysfunction (1) · Dementia (1) · Prostatic Neoplasms, Castration-Resistant (1)
AstraZeneca (1) · Deventer Ziekenhuis (1) · Janssen Pharmaceutical K.K. (1) · Northwestern University (1) · Pfizer (1) · Sanofi (1)
Belgium (2) · France (2) · Italy (2) · Netherlands (2) · Spain (2) · United Kingdom (2) · United States (2) · Australia (1) · Austria (1) · China (1) · Czechia (1) · Denmark (1) · Finland (1) · Germany (1) · Greece (1)
David VanderWeele, M.D., M.P.H. (1) · Fangjian Zhou, M.D. (1)
PMID 30028657, PMID 31566937, PMID 32926841, PMID 34274136, PMID 34450475, PMID 41186991, PMID 42020286
2014 (1), 2023 (1)